Anaplastic oligodendroglioma with ganglioglioma-like maturation

Brain Tumor Pathology

Volumn 29, Issue 4, 2012, Pages 221-228

  Tanaka, Yuko ^a   Nobusawa, Sumihito ^a   Yagi, Shinichi ^b   Ikota, Hayato ^a   Yokoo, Hideaki ^a   Nakazato, Yoichi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Kanto Neurosurgical Hospital   (Japan)

Author keywords

Fluorescence in situ hybridization; Ganglioglioma; Isocitrate dehydrogenase 1; Neuronal differentiation; Oligodendroglioma

Indexed keywords

ALPHA INTERNEXIN; CARBOPLATIN; GADOLINIUM; ISOCITRATE DEHYDROGENASE 1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MICROTUBULE ASSOCIATED PROTEIN 2; MUTANT PROTEIN; NIMUSTINE; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; SYNAPTOPHYSIN; TEMOZOLOMIDE; VINCRISTINE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; ISOCITRATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NERVE PROTEIN; OLIG2 PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN SURGERY; CASE REPORT; CHROMOSOME DELETION; CHROMOSOME DELETION 19Q; CHROMOSOME DELETION 1P; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; DRUG EFFICACY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GLIOMA; HEADACHE; HEMIPLEGIA; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IDH1 GENE; IMMUNOHISTOCHEMISTRY; INSULA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY; MULTIPLE CYCLE TREATMENT; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; OLIGODENDROGLIOMA; SEQUENCE ANALYSIS; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; TUMOR VASCULARIZATION; ULTRASTRUCTURE; CARCINOMA; CHEMISTRY; GENETICS; IMAGE PROCESSING; METABOLISM; MUTATION; PATHOLOGY;

ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA; DNA, NEOPLASM; GANGLIOGLIOMA; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; ISOCITRATE DEHYDROGENASE; MAGNETIC RESONANCE IMAGING; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUTATION; NERVE TISSUE PROTEINS; OLIGODENDROGLIOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84876424710     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-011-0078-5     Document Type: Article

References (21)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system. IARC, Lyon
2. Vyberg M, Ulhøi BP, Teglbjærg PS (2007) Neuronal features of oligodendrogliomas - an ultrastructural and immunohistochemical study. Histopathology 50:887-896 (Pubitemid 46850061)
3. Perry A, Scheithauer BW, Macaulay RJ et al (2002) Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 61:947-955 (Pubitemid 35278716)
4. Perry A, Burton SS, Fuller GN et al (2010) Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall. Acta Neuropathol 120:237-252
5. Nakazato Y, Sasaki A, Hirato J et al (1984) Immunohistochemical localization of neurofilament protein in neuronal degenerations. Acta Neuropathol 64:30-36 (Pubitemid 14095886)
6. Yokoo H, Nobusawa S, Takebayashi H et al (2004) Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 164:1717-1725 (Pubitemid 38529774)
7. Yokoo H, Kinjo S, Hirato J et al (2006) Formalin-fixed paraffin embedded specimens. Fluorescence in situ hybridization targeted for chromosome 1p of oligodendrogliomas. Rinsho Kensa 50:761-766 (in Japanese)
8. Fuller CE, Schmidt RE, Roth KA et al (2003) Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features. J Neuropathol Exp Neurol 62:1118-1128 (Pubitemid 37413823)
9. Ohgaki H, Dessen P, Jourde B et al (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892-6899 (Pubitemid 39330996)
10. Watanabe T, Nobusawa S, Kleihues P et al (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149-1153
11. Nobusawa S, Watanabe T, Kleihues P et al (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15:6002-6007
12. Buckley PG, Alcock L, Heffernan J et al (2011) Loss of chromosome 1p/19q in oligodendroglial tumors: refinement of chromosomal critical regions and evaluation of internexin immunostaining as a surrogate marker. J Neuropathol Exp Neurol 70:177-182
13. Ducray F, Mokhtari K, Crinière E et al (2010) Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas. Eur J Cancer 47:802-808
14. Capper D, Reuss D, Schittenhelm J et al (2011) Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol 121:241-252
15. Liberski PP, Kordek R (1997) Ultrastructural pathology of glial brain tumors revisited: a review. Ultrastruct Pathol 21:1-31 (Pubitemid 27099726)
16. Hartmann C, Meyer J, Balss J et al (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 118:469-474
17. Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773
18. Balss J, Meyer J, Mueller W et al (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116:597-602
19. Horbinski C, Kofler J, Yeaney G et al (2011) Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas. Brain Pathol 21:564-574
20. Ducray F, Idbaih A, de Reyniès A et al (2008) Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer 7:41 (Pubitemid 351816762)
21. Kim YH, Nobusawa S, Mittelbronn M et al (2010) Molecular classification of low-grade diffuse gliomas. Am J Pathol 177:2708-2714